SIREN : 813577079
IBIONEXT is a French company founded 10 years ago, specialized in the sector Gestion de fonds. Based in PARIS 12 (75012), this company of category PME shows in 2024 a net income positive of 3 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-18
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicador | 2024 | 2023 | 2022 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Ingresos | N/C | N/C | N/C | N/C | N/C | N/C |
| Resultado neto | 2 758 € | -213 504 € | -52 804 € | 14 178 € | 468 861 € | -68 744 € |
| EBITDA | N/C | N/C | N/C | N/C | N/C | N/C |
| Margen neto | N/C | N/C | N/C | N/C | N/C | N/C |
En 2024, IBIONEXT genera un resultado neto positivo de 3 k€.
2 758 €
El ratio de endeudamiento (= Deuda financiera / Fondos propios x 100) se sitúa en 0%. Este nivel muy bajo refleja una estructura financiera sólida. La autonomía financiera (= Fondos propios / Total activo x 100) alcanza el 33%. El equilibrio entre fondos propios y deuda es satisfactorio.
0.069%
32.547%
43.8%
En 2024, el ratio de endeudamiento de IBIONEXT (0.07) se sitúa por debajo de la mediana del sector. Este ratio mide el peso de la deuda en relación con el patrimonio. Esta posición controlada refleja una gestión prudente.
En 2024, el autonomía financiera de IBIONEXT (32.5%) se sitúa por debajo de la mediana del sector. Este ratio representa la parte del patrimonio en la financiación total. Una mejora fortalecería la posición competitiva.
El ratio de liquidez se sitúa en 123.69. La empresa tiene 2€ de activos líquidos por cada 1€ de deuda a corto plazo.
123.686
En 2024, el ratio de liquidez de IBIONEXT (123.69) se sitúa por debajo de la mediana del sector. Este ratio mide la capacidad de cubrir deuda a corto plazo con activos corrientes. Una mejora fortalecería la posición competitiva.
Based on 62 transactions of similar company sales
in 2024,
the value of IBIONEXT is estimated at
20 385 €
(range 5 787€ - 40 385€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 62 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare IBIONEXT with other companies in the same sector:
The revenue of IBIONEXT is not publicly disclosed (confidential accounts filed with INPI).
Yes, IBIONEXT generated a net profit of 3 k€ in 2024.
The headquarters of IBIONEXT is located in PARIS 12 (75012), in the department Paris.
The tax return of IBIONEXT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
IBIONEXT operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.